Clinical Trials Browser

Completed × talimogene laherparepvec × Gastrointestinal × Clear all

NCT03086642 2024-11-22

Study of Talimogene Laherparepvec (T-VEC) in Pancreatic Cancer

Phase 1 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT02509507 2024-08-06

MASTERKEY-318

Phase 1/2 Completed

127 enrolled 37 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT03256344 2024-05-14

Study of Talimogene Laherparepvec With Atezolizumab for Triple Negative Breast Cancer and Colorectal Cancer With Liver Metastases

Phase 1 Completed

36 enrolled 16 charts

BreastGastrointestinal

Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT00402025 2016-04-15

Talimogene Laherparepvec in Patients With Unresectable Pancreatic Cancer

Phase 1 Completed

17 enrolled 14 charts

Gastrointestinal

Adenocarcinoma, Neoplasm Metastasis, Pancreatic Neoplasms